A meta-analysis including 28 studies and more than 10,000 patients showed that Gal-3 level was higher in patients with persistent AF in comparison to paroxysmal AF, with Gal-3 level generally elevated in both groups, and it can predict AF development and recurrence after treatment as well [17]. This evidence concerns the gene LGALS3 and atrial fibrillation.